Predicate Device Selection
Selecting the right predicate is one of the most consequential decisions in preparing a 510(k). A weak or inappropriate predicate can result in an NSE decision or a high volume of additional information requests.
What qualifies as a predicate?โ
A valid predicate device is a device that was:
- Legally marketed before May 28, 1976 (the enactment date of the Medical Device Amendments), and has not been reclassified โ known as a "preamendments device"; OR
- Cleared through the 510(k) process after May 28, 1976; OR
- Classified through a De Novo order (which creates a new legally marketed reference)
caution
A device approved via PMA cannot serve as a predicate for a 510(k).
Finding a predicateโ
- 510(k) Database (accessdata.fda.gov) โ search cleared devices by product code, device name, or applicant name
- FDA Product Classification Database โ links cleared devices to their product code
- 510(k) Summary documents โ publicly available summaries describe the predicate used and SE rationale
Predicate selection strategyโ
A good predicate:
- Has the same intended use as your device
- Has closely similar technological characteristics
- Is recently cleared (recent predicates reflect current regulatory standards)
- Has a publicly available 510(k) summary allowing you to verify the basis of SE
Multiple predicatesโ
FDA permits the use of multiple predicates in a single 510(k):
- Use Predicate A for intended use comparison
- Use Predicate B for a specific technological characteristic
This is called a "split predicate" approach. FDA has accepted this strategy, though it requires clear and explicit justification in the submission.
The predicate chainโ
A cleared 510(k) can itself serve as a predicate for a future 510(k), creating a predicate chain. While legal, long predicate chains can create problems:
- Older predicates may no longer reflect current state of the art
- FDA may raise concerns if a predicate chain leads back to a device with known safety issues
When no predicate existsโ
If no suitable predicate exists, consider:
- De Novo classification request โ for novel, low-to-moderate risk devices
- Expanding the predicate search to a higher-level device type (general intended use)
- A Q-submission (pre-sub) to discuss predicate strategy with FDA before submitting